Company Directory > Biotech > PT Etana Biotechnologies Indonesia
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PT Etana Biotechnologies Indonesia and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
PT Etana Biotechnologies Indonesia (Etana) is an emerging biopharmaceutical company based in Jakarta, Indonesia, focused on the development, manufacturing, and commercialization of high-quality, affordable biological medicines and vaccines. The company addresses critical health needs in Indonesia, specifically targeting metabolic diseases, autoimmune disorders, infectious diseases, and oncology. Etana operates a local manufacturing facility and maintains a strong network of strategic international alliances to bring innovative therapies to the Indonesian market. By leveraging recombinant gene technology and monoclonal antibody platforms, the company aims to improve patient access to life-saving treatments.
CLASSIFICATION
Company Type:Biotech
Industry:Biotechnology
Sub-Industry:Oncology, Infectious Diseases, Metabolic Diseases
SIZE & FINANCIALS
Employees:501-1000
Founded:2014
Ownership:private
Status:operating
FUNDING
Stage:Series B
Investors:Legend Capital, UOB Venture Management, DEG, East Ventures, Yunfeng Capital, Highlight Capital
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Monoclonal antibody, Biosimilar, Vaccine
Active Trials:1
Trial Phases:Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Innovent Biologics (Bevacizumab biosimilar licensing), CanSino Biologics (Inhaled TB vaccine), University of Indonesia (Strategic research partnership), Recce Pharmaceuticals (Clinical trial partnership)
COMPETITION
Position:Emerging
Competitors:Darya-Varia, Kalbe Farma
LEADERSHIP
Key Executives:
Nathan Tirtana - CEO / President Director
Shendy MF Simamora - Head of Legal and Compliance
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PT Etana Biotechnologies Indonesia. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.